Cholangiocarcinoma

You have access
Prognostic Value of FDG-PET/CT Total Lesion Glycolysis for Patients with Resectable Distal Bile Duct Adenocarcinoma
EUN JEONG LEE, SEONG-HWAN CHANG, TAE YOON LEE, SO YOUNG YOON, YOUNG KOOG CHEON, CHAN SUP SHIM, YOUNG SO and HYUN WOO CHUNG

Anticancer Research December 2015, 35 (12) 6985-6991;
You have access
Measurement of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Cytokeratin-19 Fragment and Matrix Metalloproteinase-7 for Detecting Cholangiocarcinoma: A Preliminary Case-Control Study
FRANCO LUMACHI, GIOVANNI LO RE, RENATO TOZZOLI, FEDERICA D'AURIZIO, FLAVIO FACOMER, GIORDANO B. CHIARA and STEFANO M.M. BASSO

Anticancer Research November 2014, 34 (11) 6663-6667;
You have access
Effects of Valproic Acid in Combination with S-1 on Advanced Pancreatobiliary Tract Cancers: Clinical Study Phases I/II
SHUICHI IWAHASHI, TOHRU UTSUNOMIYA, SATORU IMURA, YUJI MORINE, TETSUYA IKEMOTO, YUSUKE ARAKAWA, YU SAITO, DAICHI ISHIKAWA and MITSUO SHIMADA

Anticancer Research September 2014, 34 (9) 5187-5191;
You have access
Hepatic Arterial Infusion for Biliary Tract Carcinoma: Single-center Experience
BOHUSLAV MELICHAR, ZBYNĚK VOBOŘIL, JOSEF DVOŘÁK, ALEXANDER FERKO, TOMÁŠ ROZKOŠ and ANTONÍN KRAJINA

Anticancer Research March 2013, 33 (3) 1201-1207;
You have access
Gefitinib and Gemcitabine Coordinately Inhibited the Proliferation of Cholangiocarcinoma Cells
YOSHIMI NAKAJIMA, HITOSHI TAKAGI, SATORU KAKIZAKI, NORIO HORIGUCHI, KEN SATO, NORIAKI SUNAGA and MASATOMO MORI

Anticancer Research December 2012, 32 (12) 5251-5262;
You have access
Genetic and Molecular Abnormalities in Cholangiocarcinogenesis
VICTOR J. HASSID, FRANK A. ORLANDO, ZIAD T. AWAD, DONGFENG TAN, THAER KHOURY, BESTOUN H. AHMED and SADIR J. ALRAWI

Anticancer Research April 2009, 29 (4) 1151-1156; DOI: https://doi.org/10.21873/anticanres.16345

Main menu

User menu

Search

Cholangiocarcinoma

Pages